Literature DB >> 12411328

Deficiency of ADAMTS13 and thrombotic thrombocytopenic purpura.

Han-Mou Tsai.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12411328     DOI: 10.1182/blood-2002-07-2241

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  5 in total

1.  Rituximab for managing relapsing or refractory patients with idiopathic thrombotic thrombocytopenic purpura--haemolytic uraemic syndrome.

Authors:  Domenica Caramazza; Gerlando Quintini; Ignazio Abbene; Lucio Lo Coco; Alessandra Malato; Rosa Di Trapani; Giorgia Saccullo; Giuseppina Pizzo; Roberto Palazzolo; Rita Barone; Giuseppina Mazzola; Sergio Rizzo; Paolo Ragonese; Paolo Aridon; Vincenzo Abbadessa; Sergio Siragusa
Journal:  Blood Transfus       Date:  2010-07       Impact factor: 3.443

2.  Response to "Predictors of survival in thrombotic thrombocytopenic purpura" Haematologica 2013;98(5):e58.

Authors:  Paul Coppo
Journal:  Haematologica       Date:  2013-07       Impact factor: 9.941

3.  Comparison of the efficacy and safety of caplacizumab versus placebo in thrombotic thrombocytopenic purpura: a meta-analysis and systematic review based on randomized controlled trials.

Authors:  Bin Chen; Xihong Li; Dongqiong Xiao; Rodrigo Daminello Raimundo; Ruixi Zhou; Yupeng Lei
Journal:  Ann Transl Med       Date:  2022-06

4.  Predictors of relapse and efficacy of rituximab in immune thrombotic thrombocytopenic purpura.

Authors:  Lova Sun; Johnathan Mack; Ang Li; Justine Ryu; Vivek A Upadhyay; Lynne Uhl; Richard M Kaufman; Christopher P Stowell; Walter S Dzik; Robert S Makar; Pavan K Bendapudi
Journal:  Blood Adv       Date:  2019-05-14

5.  Association between ADAMTS13 deficiency and cardiovascular events in chronic hemodialysis patients.

Authors:  Shih-Yuan Hung; Tsun-Mei Lin; Hung-Hsiang Liou; Ching-Yang Chen; Wei-Ting Liao; Hsi-Hao Wang; Li-Chun Ho; Ching-Fang Wu; Yi-Che Lee; Min-Yu Chang
Journal:  Sci Rep       Date:  2021-11-24       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.